Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

medroxyprogesterone acetate has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooney, R; Hayward, P1
Fowler, R; Imrie, K1

Other Studies

2 other study(ies) available for medroxyprogesterone acetate and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Highlights from the 21st CROI.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:4

    Topics: Animals; Anti-HIV Agents; Child; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Hepatitis C; HIV Infections; Humans; Infant, Newborn; Male; Medication Adherence; Medroxyprogesterone Acetate; Norethindrone

2014
Thalidomide-associated hepatitis: a case report.
    American journal of hematology, 2001, Volume: 66, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Dexamethasone; Doxorubicin; Estrogens, Conjugated (USP); Fatal Outcome; Female; Hepatitis C; Humans; Leukemia, Plasma Cell; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Salvage Therapy; Thalidomide; Thrombocytopenia; Vincristine

2001